Aura Biosciences, Inc. (AURA) earnings
AURA earnings moved a median of +0.73% by the close. Quarterly and annual AURA reports and results, each read against the price at its own news timestamp. Back to the AURA overview →
22 measured AURA earnings events.
Where these AURA earnings landedvs 20 measured AURA earnings reactions
| Middle 50% of AURA earnings reactions | -1.19% to +3.29% |
|---|---|
| Median reaction (to close) | +0.73% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 AURA earnings events with a measured close landed between -1.19% and +3.29%; 70% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Aura Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights | Press release | -2.25% | +6.49% | |
| Form 10-Q Aura Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.25% | +6.49% | |
| Aura Biosciences Reports First Quarter 2026 Financial Results and Business Highlights | Press release | +0.25% | +0.64% | |
| Form 10-Q Aura Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.25% | +0.64% | |
| Form 10-K Aura Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.44% | -1.12% | |
| Aura Biosciences Reports Third Quarter 2025 Financial Results and Business Highlights | Press release | +0.09% | — | |
| Form 10-Q Aura Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.09% | — | |
| Aura Biosciences Reports Second Quarter 2025 Financial Results and Business Highlights | Press release | +0.50% | +3.29% | |
| Form 10-Q Aura Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.50% | +3.29% | |
| Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights | Press release | +9.05% | +14.35% | |
| Form 10-Q Aura Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | +9.05% | +14.35% | |
| Form 10-K Aura Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.57% | +1.72% | |
| Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights | Press release | -3.67% | -6.43% | |
| Form 10-Q Aura Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | -3.67% | -6.43% | |
| Aura Biosciences Reports Second Quarter 2024 Financial Results and Business Highlights | Press release | -13.32% | -9.80% | |
| Form 10-Q Aura Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | -13.32% | -9.80% | |
| Form 10-K/A Aura Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +2.63% | |
| Aura Biosciences Reports First Quarter 2024 Financial Results and Business Highlights | Press release | -0.80% | +0.67% | |
| Form 10-Q Aura Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.80% | +0.67% | |
| Form 10-K Aura Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | +3.33% | -1.41% | |
| Aura Biosciences Reports Third Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights | Press release | +1.05% | +0.79% | |
| Form 10-Q Aura Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.05% | +0.79% |
Keep exploring
More AURA: analyst actions → · SEC filings → · AURA overview →